Loading chat...
OH SB227
Bill
Status
Introduced
7/1/2025
Primary Sponsor
Hearcel Craig
Click for details
AI Summary
-
Caps patient cost sharing for prescription insulin at $35 per 30-day supply, regardless of the amount or type of insulin prescribed
-
Applies to all health benefit plans amended, issued, or renewed on or after the bill's effective date
-
Defines "prescription insulin drug" as any prescription drug containing insulin used to treat diabetes
-
Cost sharing is charged on a per-prescription-fill basis
-
Overrides existing Ohio Revised Code section 3901.71 to implement this cap on health plan issuers
Legislative Description
Cap cost sharing for prescription insulin drugs
Health and Human Services : Public Health
Last Action
Referred to committee: Financial Institutions, Insurance and Technology
10/1/2025
Committee Referrals
Financial Institutions, Insurance and Technology10/1/2025
Full Bill Text
No bill text available